Allergan Aesthetics Hits Milestone: 100 Million Syringes of JUVÉDERM Shipped

September 7, 2022
Allergan Aesthetics Hits Milestone 100 Million Syringes of JUVDERM Shipped image

 Since its launch in 2000, the JUVÉDERM Collection of Fillers has grown to where its products are now available in more than 110 territories worldwide.  

Drumroll, please…Allergan Aesthetics, an AbbVie company has produced and shipped 100 million syringes of JUVÉDERM products globally. 

 Since its launch in 2000, the JUVÉDERM Collection of Fillers has grown to where its products are now available in more than 110 territories worldwide.  

"This is more than just a number. 100 million JUVÉDERM syringes is a great source of pride for everyone at Allergan Aesthetics who helped make this happen," says Carrie Strom, President, Global Allergan Aesthetics and Senior Vice President, AbbVie, in a news release. "It represents the millions of patients who've benefitted from our innovation and robust product offerings. We couldn't have done this without the years of support from all our healthcare professionals who continue to believe in and trust our products. We look forward to forging ahead as a brand, setting new goals, and continuing our legacy as the international category leader."

"I am thrilled to celebrate this momentous occasion alongside the JUVÉDERM Collection of Fillers. I trust the brand in my practice and have successfully offered it for more than 15 years," says Dr. David Shafer, New York City-based board-certified plastic surgeon. "Sixteen years of clinical studies and safety data, the widest range of filler options, and their rigorous testing protocols to ensure patient safety are just some of the reasons why I offer JUVÉDERM products to my patients. I look forward to the continued innovation from the JUVÉDERM Collection of Fillers and the rest of the Allergan Aesthetics portfolio for many years to come."

In the U.S., the JUVÉDERM Collection of Fillers includes: 

  • JUVÉDERM VOLUMA XC
  • JUVÉDERM Ultra Plus XC
  •  JUVÉDERM VOLLURE XC
  • JUVÉDERM Ultra XC
  •  JUVÉDERM VOLBELLA XC

The latest product approved by the FDA, JUVÉDERM VOLUX  XC for improvement of jawline definition, will be available nationwide in early 2023

"I've had the honor of serving as an Allergan Medical Institute (AMI) trainer for more than six years. The training Allergan Aesthetics provides focuses on facial anatomy, considerations for safe injection, appropriate patient selection, and aseptic technique," says Shawna Chrisman, NP. "I work closely with aesthetic specialists across the country to help them use the JUVÉDERM Collection of Fillers to achieve their patients' aesthetic goals and am truly honored to be a part of this brand's rich history and bright future."

Facebook Comments

Register

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free